Back to User profile » Dr J Mark FitzGerald
Papers published by Dr J Mark FitzGerald:
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, Ariti C, Garcia Gil E, Newell A, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, Bulathsinhala L, von Bülow A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtimäki LA, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Sirena C, Papadopoulos N, Papaioannou AI, Pérez de Llano L, Perng DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taillé C, Taube C, Torres-Duque CA, Ulrik CS, Ra SW, Wang E, Wechsler ME, Price DB
Journal of Asthma and Allergy 2022, 15:1491-1510
Published Date: 21 October 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Menzies-Gow AN, McBrien C, Unni B, Porsbjerg CM, Al-Ahmad M, Ambrose CS, Dahl Assing K, von Bülow A, Busby J, Cosio BG, FitzGerald JM, Garcia Gil E, Hansen S, Heaney LG, Hew M, Jackson DJ, Kallieri M, Loukides S, Lugogo NL, Papaioannou AI, Larenas-Linnemann D, Moore WC, Perez-de-Llano LA, Rasmussen LM, Schmid JM, Siddiqui S, Alacqua M, Tran TN, Suppli Ulrik C, Upham JW, Wang E, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Murray RB, Price CA, Price DB
Journal of Asthma and Allergy 2022, 15:63-78
Published Date: 13 January 2022
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care
Busby J, Price D, Al-Lehebi R, Bosnic-Anticevich S, van Boven JFM, Emmanuel B, FitzGerald JM, Gaga M, Hansen S, Hew M, Iwanaga T, Larenas Linnemann D, Mahboub B, Mitchell P, Morrone D, Pham J, Porsbjerg C, Roche N, Wang E, Eleangovan N, Heaney LG
Journal of Asthma and Allergy 2021, 14:1375-1388
Published Date: 10 November 2021
Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials
Begg M, Hamblin JN, Jarvis E, Bradley G, Mark S, Michalovich D, Lennon M, Wajdner HE, Amour A, Wilson R, Saunders K, Tanaka R, Arai S, Tang T, Van Holsbeke C, De Backer J, Vos W, Titlestad IL, FitzGerald JM, Killian K, Bourbeau J, Poirier C, Maltais F, Cahn A, Hessel EM
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1621-1636
Published Date: 3 June 2021
The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
Leung C, Bourbeau J, Sin DD, Aaron SD, FitzGerald JM, Maltais F, Marciniuk DD, O'Donnell D, Hernandez P, Chapman KR, Walker B, Road JD, Zheng L, Zou C, Hogg JC, Tan WC
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:305-320
Published Date: 12 February 2021
Development and Pretesting of a New Functional-Based Health Literacy Measurement Tool for Chronic Obstructive Pulmonary Disease (COPD) and Asthma Management
Poureslami I, Shum J, Kopec J, Sawatzky R, Gupta S, Pakhale S, Kassay S, Starnes K, Akhtar A, FitzGerald JM
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:613-625
Published Date: 20 March 2020
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ
Journal of Asthma and Allergy 2019, 12:401-413
Published Date: 9 December 2019
Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
Tavakoli H, Johnson KM, FitzGerald JM, Sin DD, Gershon AS, Kendzerska T, Sadatsafavi M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2003-2013
Published Date: 3 September 2019
Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey
Gruffydd-Jones K, Thomas M, Roman-Rodríguez M, Infantino A, FitzGerald JM, Pavord I, Haddon JM, Elsasser U, Vogelberg C
Journal of Asthma and Allergy 2019, 12:183-194
Published Date: 11 July 2019
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples
Alotaibi NM, Chen V, Hollander Z, Leipsic JA, Hague CJ, Murphy DT, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:311-319
Published Date: 23 January 2019
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
Johnson KM, Safari A, Tan WC, Bourbeau J, FitzGerald JM, Sadatsafavi M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3983-3995
Published Date: 13 December 2018
Phenotyping COPD exacerbations using imaging and blood-based biomarkers
Alotaibi NM, Chen V, Hollander Z, Hague CJ, Murphy DT, Leipsic JA, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:217-229
Published Date: 8 January 2018
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates
Alshabanat A, Otterstatter MC, Sin DD, Road J, Rempel C, Burns J, van Eeden SF, FitzGerald JM
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:961-971
Published Date: 21 March 2017
Current recommendations for the treatment of mild asthma
Neal Shahidi, J Mark FitzGerald
Journal of Asthma and Allergy 2010, 3:169-176
Published Date: 8 December 2010